CD28 costimulation: from mechanism to therapy

JH Esensten, YA Helou, G Chopra, A Weiss… - Immunity, 2016 - cell.com
Ligation of the CD28 receptor on T cells provides a critical second signal alongside T cell
receptor (TCR) ligation for naive T cell activation. Here, we discuss the expression, structure …

[HTML][HTML] Skin cancers in organ transplant recipients

A Mittal, OR Colegio - American Journal of Transplantation, 2017 - Elsevier
Long-term utilization of immunosuppression in organ transplant recipients (OTRs) leads to
decreased immune-mediated tumor surveillance and development of malignant tumors. A …

Calcineurin inhibitors: 40 years later, can't live without…

JR Azzi, MH Sayegh, SG Mallat - The Journal of Immunology, 2013 - journals.aai.org
Calcineurin inhibitors (CNIs) revolutionized the field of organ transplantation and remain the
standard of care 40 years after the discovery of cyclosporine. The early impressive results of …

Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics

T Rath, K Baker, JA Dumont, RT Peters… - Critical reviews in …, 2015 - Taylor & Francis
Nearly 350 IgG-based therapeutics are approved for clinical use or are under development
for many diseases lacking adequate treatment options. These include molecularly …

Belatacept for kidney transplant recipients

P Masson, L Henderson, JR Chapman… - Cochrane Database …, 2014 - cochranelibrary.com
Background Most people who receive a kidney transplant die from either cardiovascular
disease or cancer before their transplant fails. The most common reason for someone with a …

Cell-based therapy for degenerative retinal disease

M Zarbin - Trends in molecular medicine, 2016 - cell.com
Stem cell-derived retinal pigment epithelium (RPE) and photoreceptors (PRs) have restored
vision in preclinical models of human retinal degenerative disease. This review discusses …

[HTML][HTML] Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys

JOM Pestana, JM Grinyo, Y Vanrenterghem… - American journal of …, 2012 - Elsevier
Recipients of extended-criteria donor (ECD) kidneys have poorer long-term outcomes
compared to standard-criteria donor kidney recipients. We report 3-year outcomes from a …

Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches

R Diehl, F Ferrara, C Müller, AY Dreyer… - Cellular & Molecular …, 2017 - nature.com
Almost every experimental treatment strategy using non-autologous cell, tissue or organ
transplantation is tested in small and large animal models before clinical translation …

Targeting co-stimulatory pathways: transplantation and autoimmunity

ML Ford, AB Adams, TC Pearson - Nature Reviews Nephrology, 2014 - nature.com
The myriad of co-stimulatory signals expressed, or induced, upon T-cell activation suggests
that these signalling pathways shape the character and magnitude of the resulting …

Post-transplant cardiovascular disease

KA Birdwell, M Park - Clinical Journal of the American Society of …, 2021 - journals.lww.com
Cardiovascular disease remains a leading cause of death and morbidity in kidney transplant
recipients and a common reason for post-transplant hospitalization. Several traditional and …